Vivani Medical (VANI) Form 4 SECOND SIGHT MEDICAL PRODUCTS / Robert J. Greenberg ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Greenberg Robert J.

(Last) (First) (Middle)

12744 SAN FERNANDO ROAD

SUITE 400

(Street)

SYLMAR CA 91342

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SECOND SIGHT MEDICAL PRODUCTS INC [ EYES ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chairman of Board

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/31/2017	05/31/2017	A		13,090	A	$0.978	186,001(1)	D
Common Stock	06/05/2017	06/05/2017	A		13,090	D	$1.13	172,911(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$1.97							01/03/2018(2)	01/03/2027	Common Stock	256,410		256,410	D
Non-Qualified Stock Option (right to buy)	$4.1							01/21/2017(2)	01/21/2026	Common Stock	57,563		57,563	D
Non-Qualified Stock Option (right to buy)	$5							02/01/2009(3)	02/01/2018	Common Stock	23,750		23,750	D
Non-Qualified Stock Option (right to buy)	$5							11/01/2009(3)	11/01/2018	Common Stock	150,000		150,000	D
Non-Qualified Stock Option (right to buy)	$5							02/01/2010(3)	02/01/2019	Common Stock	33,750		33,750	D
Non-Qualified Stock Option (right to buy)	$5							02/01/2011(3)	02/01/2020	Common Stock	103,750		103,750	D
Non-Qualified Stock Option (right to buy)	$5							03/01/2012(3)	03/01/2021	Common Stock	41,563		41,563	D
Non-Qualified Stock Option (right to buy)	$5							03/01/2013(3)	03/01/2022	Common Stock	38,750		38,750	D
Non-Qualified Stock Option (right to buy)	$5							04/01/2015(3)	04/01/2024	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (right to buy)	$9							09/26/2015(3)	09/26/2024	Common Stock	414,659		414,659	D
Non-Qualified Stock Option (right to buy)	$13.09							03/25/2016(3)	03/25/2025	Common Stock	31,250		31,250	D

Explanation of Responses:

1. 13,090 shares, acquired as part of scheduled ESPP purchases, were sold on 6/5/2017.

2. Options vest over a four year term of which one-fourth vests on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter.

3. Options vest in 4 yearly increments starting with the Date Exercisable

	/s/ Robert J Greenberg	06/07/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.